DUBLIN, Ireland, May 27, 2014 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve protein misfolding or cell adhesion, announced today that Dale Schenk, PhD, the Company’s President and Chief Executive Officer, will be presenting at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3, 2014, at 8:00 AM ET. The conference will be held at The Grand Hyatt New York.
Help employers find you! Check out all the jobs and post your resume.
